Smart dosing trial aims to tailor antibiotics for seniors
NCT ID NCT07127185
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tests a personalized approach to dosing the antibiotic ceftobiprole in people aged 60 and older. Researchers will measure drug levels in the blood and use computer models to adjust each patient's dose, aiming to improve effectiveness and reduce side effects. The goal is to create a smarter dosing system that can be used for other antibiotics in elderly patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEFTOBIPROLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.